Evidence map›Paper›PMID 42482505›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Engineering "Yin-Yang" Ag/AgCl-Polymer Nanotherapeutic for Tunable Silver Ion Release With Improved In Vivo Biocompatibility and Antimicrobial Potency.

Dipanjana Patra, Jayanta Haldar

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dipanjana PatraChemistry and Physics of Materials Unit, Jawaharlal Nehru Centre For Advanced Scientific Research (JNCASR), Bengaluru, Karnataka, India.
Jayanta HaldarAntimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre For Advanced Scientific Research (JNCASR), Bengaluru, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid insurgence of antimicrobial resistance poses a critical threat to global health exacerbated by the dwindling supply of the effective arsenal of therapeutics. Nanomaterials provide alternative strategies by enabling novel antimicrobials that evade pathogens' intrinsic defense systems; yet their translation is constrained by complex synthesis, limited activity, and suboptimal invivo biocompatibility and efficacy. Silver-based systems rely on the release of Ag

Indexed as

Anti-Infective AgentsBiocompatible MaterialsPolymersSilverSilver CompoundsAnimalsBiofilmsCandida albicansIonsMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsNanocompositesZebrafishAnti-Infective AgentsBiocompatible MaterialsIonsPolymersSilversilver chlorideSilver CompoundsAg/AgCl biphasic nanoparticleantimicrobial resistancepolymeric‐nanocompositepolymicrobial biofilmtopical infections

Identifiers

PMID42482505
PMCPMC13580315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.